Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/15283
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSadia Ashraf-
dc.contributor.authorTanweer Khaliq-
dc.contributor.authorIjaz Javed-
dc.contributor.authorBilal Aslam-
dc.contributor.authorNazia Qadir-
dc.contributor.authorNadia Noor-
dc.date.accessioned2022-12-19T10:04:19Z-
dc.date.available2022-12-19T10:04:19Z-
dc.date.issued2018-01-20-
dc.identifier.citationAshraf, S., Khaliq, T., Javed, I., Aslam, B., Qadir, N., & Noor, N. (2018). Disposition kinetics of omeprazole in healthy female volunteers in Pakistan. Pakistan Journal of Pharmaceutical Sciences, 31(1).en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/15283-
dc.description.abstractOmeprazole (OMP) a proton pump inhibitor is widely used to suppress gastric acid secretions of parietal cells of stomach and metabolized predominantly by CYP2C19. The objective of the present study was to investigate the pharmacokinetics and dosage regimen of OMP, after its single oral administration in eight healthy adult female subjects. Blood samples were collected at different time intervals after oral administration and their pH was measured. Plasma concentration of OMP was determined by high performance liquid chromatography (HPLC) system equipped with UVvisible Detector. The concentration versus time data was used to compute the pharmacokinetic parameters with the help of computer software programme MW/PHRAM APO version 3.02.Peak plasma concentration was (Cmax) 0.38±0.04 µg/ml achieved at 2.07±0.22 hrs. The elimination half-life (t1/2β) was1.82±0.42 hrs. Volume of distribution (Vd) in the present study was 0.40±0.07 l/kg with total body clearance (ClB) 0.19±0.02 l/hr/kg and area under the curve (AUC) 1.89 ±0.23 µg.hr/ml.The pharmacokinetic properties which are different from the literature after oral administration of 20 mg OMP in eight healthy female volunteers may be due to the variations of environment and genetic variation between Pakistan and drug manufacturing of foreign countries.en_US
dc.language.isoenen_US
dc.publisherKarachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi.en_US
dc.subjectOmeprazoleen_US
dc.subjectPharmacokinetic parametersen_US
dc.subjectpeak plasma concentrationen_US
dc.subjectelimination half-lifeen_US
dc.subjectvolume of distributionen_US
dc.titleDisposition kinetics of omeprazole in healthy female volunteers in Pakistanen_US
dc.typeArticleen_US
Appears in Collections:Issue 01

Files in This Item:
File Description SizeFormat 
Paper-28.htm132 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.